HURA

TUHURA BIOSCIENCES INC

HURA·898920103·US·Common Stock·Healthcare - Biotechnology-Activist

HURA (TUHURA BIOSCIENCES INC) is held by 54 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($5.3M), NORTHERN TRUST CORP ($3.8M), BlackRock, Inc. ($1.6M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 24 funds bought HURA.

54
Holders
(5 Elite)
$19.1M
Total Value
39% (61)
Consensus
24 buying - 37 selling
13F: Insider & Congress: Updated regularly
HURA

Smart Money Verdict

View all
Loading verdict
Held by 54 funds
5 elite

Who's Trading

Source dates: Price Sep 21, 2026 · Insiders none · Activists Aug 28, 2026 · Congress Aug 9, 2025

ActivistJAJames A. Bianco, M.D.4.6%Aug 28, 2026
ActivistHIHighbridge Capital Management, LLC9.1%Feb 17, 2026
ActivistThe Vanguard GroupThe Vanguard Group4.4%Oct 31, 2025
Checking access…

Top Holders

Checking access…
Action
Increased
2.3M(+9.3%)$5.3M0.0%+25.50%
30
Increased
1.6M(+443.6%)$3.8M0.0%-13.10%
43
Decreased
690,088(-71.8%)$1.6M0.0%-10.99%
0
Decreased
484,219(-50.9%)$1.1M0.0%-19.13%
0
New
454,535$1.1M0.0%-13.25%
35
Decreased
424,600(-30.1%)$993,5630.0%+28.89%
0
Decreased
251,186(-12.5%)$587,7750.0%+30.97%
0
New
232,319$543,6270.0%-13.25%
34
Decreased
188,404(-63.3%)$440,8650.0%+0.35%
0
New
163,891$383,5050.0%-13.25%
36
New
145,595$340,6920.0%-13.25%
33
Increased
143,257(+501.1%)$335,2220.0%-4.18%
26
Increased
131,768(+87.6%)$308,3370.0%+20.51%
25
Decreased
121,662(-42.5%)$284,6890.0%-4.51%
0
Increased
100,424(+772.3%)$234,9920.0%-9.75%
37
New
88,373$206,7930.0%-13.25%
32
Decreased
61,620(-56.1%)$144,1910.0%+30.97%
0
Decreased
56,321(-9.3%)$131,7910.0%-9.08%
0
New
45,115$105,5690.0%-13.25%
30
Decreased
42,506(-45.6%)$99,4640.0%+65.24%
0

Showing 1-20 of 69

1 / 4
HURAHURATUHURA BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used